Incontinence after Prostate Treatment: AUA/SUFU Guideline

Jaspreet S. Sandhu, Benjamin Breyer, Craig Comiter, James A. Eastham, Christopher Gomez, Daniel J. Kirages, Chris Kittle, Alvaro Lucioni, Victor W. Nitti, John T. Stoffel, O. Lenaine Westney, M. Hassan Murad, Kurt McCammon

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Urinary incontinence after prostate treatment (IPT) is one of the few urologic diseases that is iatrogenic, and, therefore, predictable and perhaps preventable. Evaluation of the incontinent patient, risk factors for IPT, the assessment of the patient prior to intervention, and a stepwise approach to management are covered in this guideline. Algorithms for patient evaluation, surgical management, and device failure are also provided.Materials and Methods:This guideline was developed using a systematic review from the Mayo Clinic Evidence Based Practice Center with additional supplementation by the authors. A research librarian conducted searches from 2000 to December 21st, 2017 using Ovid, MEDLINE, Cochrane Central Register of Controlled Trials, and Cochrane Databases of Systematic Reviews. Additional references through 12/31/2018 were identified.Results:This guideline was developed by a multi-disciplinary panel to inform clinicians on the proper assessment of patients with IPT and the safe and effective management of the condition in both surgical and non-surgical contexts. Statements guiding the clinician on proper management of device failure are also included.Conclusion:Most patients who undergo radical prostatectomy (RP), and some patients who undergo radiation therapy (RT) or surgery for benign prostatic hyperplasia (BPH), will experience IPT. Although non-surgical options, such as pelvic floor muscle exercises (PFME), can hasten continence recovery, patients who remain incontinent at one-year post-procedure, or have severe incontinence at six months, may elect to undergo surgical treatment (e.g. artificial urinary sphincter). Prior to IPT surgery, the risks, benefits, alternatives, and additional likely procedures should be discussed with the patient.

Original languageEnglish (US)
Pages (from-to)369-378
Number of pages10
JournalJournal of Urology
Volume202
Issue number2
DOIs
StatePublished - Aug 1 2019
Externally publishedYes

Fingerprint

Prostate
Guidelines
Equipment Failure
Therapeutics
Artificial Urinary Sphincter
Librarians
Urologic Diseases
Pelvic Floor
Evidence-Based Practice
Prostatic Hyperplasia
Urinary Incontinence
Prostatectomy
MEDLINE
Radiotherapy
Databases
Exercise
Muscles
Research

Keywords

  • prostate
  • prostatectomy
  • radiotherapy
  • transurethral resection of prostate
  • urinary continence

ASJC Scopus subject areas

  • Urology

Cite this

Sandhu, J. S., Breyer, B., Comiter, C., Eastham, J. A., Gomez, C., Kirages, D. J., ... McCammon, K. (2019). Incontinence after Prostate Treatment: AUA/SUFU Guideline. Journal of Urology, 202(2), 369-378. https://doi.org/10.1097/JU.0000000000000314

Incontinence after Prostate Treatment : AUA/SUFU Guideline. / Sandhu, Jaspreet S.; Breyer, Benjamin; Comiter, Craig; Eastham, James A.; Gomez, Christopher; Kirages, Daniel J.; Kittle, Chris; Lucioni, Alvaro; Nitti, Victor W.; Stoffel, John T.; Westney, O. Lenaine; Murad, M. Hassan; McCammon, Kurt.

In: Journal of Urology, Vol. 202, No. 2, 01.08.2019, p. 369-378.

Research output: Contribution to journalArticle

Sandhu, JS, Breyer, B, Comiter, C, Eastham, JA, Gomez, C, Kirages, DJ, Kittle, C, Lucioni, A, Nitti, VW, Stoffel, JT, Westney, OL, Murad, MH & McCammon, K 2019, 'Incontinence after Prostate Treatment: AUA/SUFU Guideline', Journal of Urology, vol. 202, no. 2, pp. 369-378. https://doi.org/10.1097/JU.0000000000000314
Sandhu JS, Breyer B, Comiter C, Eastham JA, Gomez C, Kirages DJ et al. Incontinence after Prostate Treatment: AUA/SUFU Guideline. Journal of Urology. 2019 Aug 1;202(2):369-378. https://doi.org/10.1097/JU.0000000000000314
Sandhu, Jaspreet S. ; Breyer, Benjamin ; Comiter, Craig ; Eastham, James A. ; Gomez, Christopher ; Kirages, Daniel J. ; Kittle, Chris ; Lucioni, Alvaro ; Nitti, Victor W. ; Stoffel, John T. ; Westney, O. Lenaine ; Murad, M. Hassan ; McCammon, Kurt. / Incontinence after Prostate Treatment : AUA/SUFU Guideline. In: Journal of Urology. 2019 ; Vol. 202, No. 2. pp. 369-378.
@article{93f6fc61e50b472fbd1a1ff5ef40cf1b,
title = "Incontinence after Prostate Treatment: AUA/SUFU Guideline",
abstract = "Urinary incontinence after prostate treatment (IPT) is one of the few urologic diseases that is iatrogenic, and, therefore, predictable and perhaps preventable. Evaluation of the incontinent patient, risk factors for IPT, the assessment of the patient prior to intervention, and a stepwise approach to management are covered in this guideline. Algorithms for patient evaluation, surgical management, and device failure are also provided.Materials and Methods:This guideline was developed using a systematic review from the Mayo Clinic Evidence Based Practice Center with additional supplementation by the authors. A research librarian conducted searches from 2000 to December 21st, 2017 using Ovid, MEDLINE, Cochrane Central Register of Controlled Trials, and Cochrane Databases of Systematic Reviews. Additional references through 12/31/2018 were identified.Results:This guideline was developed by a multi-disciplinary panel to inform clinicians on the proper assessment of patients with IPT and the safe and effective management of the condition in both surgical and non-surgical contexts. Statements guiding the clinician on proper management of device failure are also included.Conclusion:Most patients who undergo radical prostatectomy (RP), and some patients who undergo radiation therapy (RT) or surgery for benign prostatic hyperplasia (BPH), will experience IPT. Although non-surgical options, such as pelvic floor muscle exercises (PFME), can hasten continence recovery, patients who remain incontinent at one-year post-procedure, or have severe incontinence at six months, may elect to undergo surgical treatment (e.g. artificial urinary sphincter). Prior to IPT surgery, the risks, benefits, alternatives, and additional likely procedures should be discussed with the patient.",
keywords = "prostate, prostatectomy, radiotherapy, transurethral resection of prostate, urinary continence",
author = "Sandhu, {Jaspreet S.} and Benjamin Breyer and Craig Comiter and Eastham, {James A.} and Christopher Gomez and Kirages, {Daniel J.} and Chris Kittle and Alvaro Lucioni and Nitti, {Victor W.} and Stoffel, {John T.} and Westney, {O. Lenaine} and Murad, {M. Hassan} and Kurt McCammon",
year = "2019",
month = "8",
day = "1",
doi = "10.1097/JU.0000000000000314",
language = "English (US)",
volume = "202",
pages = "369--378",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Incontinence after Prostate Treatment

T2 - AUA/SUFU Guideline

AU - Sandhu, Jaspreet S.

AU - Breyer, Benjamin

AU - Comiter, Craig

AU - Eastham, James A.

AU - Gomez, Christopher

AU - Kirages, Daniel J.

AU - Kittle, Chris

AU - Lucioni, Alvaro

AU - Nitti, Victor W.

AU - Stoffel, John T.

AU - Westney, O. Lenaine

AU - Murad, M. Hassan

AU - McCammon, Kurt

PY - 2019/8/1

Y1 - 2019/8/1

N2 - Urinary incontinence after prostate treatment (IPT) is one of the few urologic diseases that is iatrogenic, and, therefore, predictable and perhaps preventable. Evaluation of the incontinent patient, risk factors for IPT, the assessment of the patient prior to intervention, and a stepwise approach to management are covered in this guideline. Algorithms for patient evaluation, surgical management, and device failure are also provided.Materials and Methods:This guideline was developed using a systematic review from the Mayo Clinic Evidence Based Practice Center with additional supplementation by the authors. A research librarian conducted searches from 2000 to December 21st, 2017 using Ovid, MEDLINE, Cochrane Central Register of Controlled Trials, and Cochrane Databases of Systematic Reviews. Additional references through 12/31/2018 were identified.Results:This guideline was developed by a multi-disciplinary panel to inform clinicians on the proper assessment of patients with IPT and the safe and effective management of the condition in both surgical and non-surgical contexts. Statements guiding the clinician on proper management of device failure are also included.Conclusion:Most patients who undergo radical prostatectomy (RP), and some patients who undergo radiation therapy (RT) or surgery for benign prostatic hyperplasia (BPH), will experience IPT. Although non-surgical options, such as pelvic floor muscle exercises (PFME), can hasten continence recovery, patients who remain incontinent at one-year post-procedure, or have severe incontinence at six months, may elect to undergo surgical treatment (e.g. artificial urinary sphincter). Prior to IPT surgery, the risks, benefits, alternatives, and additional likely procedures should be discussed with the patient.

AB - Urinary incontinence after prostate treatment (IPT) is one of the few urologic diseases that is iatrogenic, and, therefore, predictable and perhaps preventable. Evaluation of the incontinent patient, risk factors for IPT, the assessment of the patient prior to intervention, and a stepwise approach to management are covered in this guideline. Algorithms for patient evaluation, surgical management, and device failure are also provided.Materials and Methods:This guideline was developed using a systematic review from the Mayo Clinic Evidence Based Practice Center with additional supplementation by the authors. A research librarian conducted searches from 2000 to December 21st, 2017 using Ovid, MEDLINE, Cochrane Central Register of Controlled Trials, and Cochrane Databases of Systematic Reviews. Additional references through 12/31/2018 were identified.Results:This guideline was developed by a multi-disciplinary panel to inform clinicians on the proper assessment of patients with IPT and the safe and effective management of the condition in both surgical and non-surgical contexts. Statements guiding the clinician on proper management of device failure are also included.Conclusion:Most patients who undergo radical prostatectomy (RP), and some patients who undergo radiation therapy (RT) or surgery for benign prostatic hyperplasia (BPH), will experience IPT. Although non-surgical options, such as pelvic floor muscle exercises (PFME), can hasten continence recovery, patients who remain incontinent at one-year post-procedure, or have severe incontinence at six months, may elect to undergo surgical treatment (e.g. artificial urinary sphincter). Prior to IPT surgery, the risks, benefits, alternatives, and additional likely procedures should be discussed with the patient.

KW - prostate

KW - prostatectomy

KW - radiotherapy

KW - transurethral resection of prostate

KW - urinary continence

UR - http://www.scopus.com/inward/record.url?scp=85069295449&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069295449&partnerID=8YFLogxK

U2 - 10.1097/JU.0000000000000314

DO - 10.1097/JU.0000000000000314

M3 - Article

C2 - 31059663

AN - SCOPUS:85069295449

VL - 202

SP - 369

EP - 378

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 2

ER -